XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed and Consolidated Balance Sheets (unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 5,878,215 $ 1,133,113
Reimbursement receivable   17,014,631
Prepaid expenses 146,599 122,301
Derivative assets 1,810,000 2,353,677
Total current assets 7,834,814 20,623,722
Investments held in Trust Account 350,055,777 350,027,211
Total assets 357,890,591 370,650,933
Current liabilities:    
Accrued professional fees and other expenses 1,416,793 7,347,195
Note payable to Sponsor   6,000,000
Deferred underwriting compensation 12,250,000 12,250,000
Derivative liabilities 10,990,000 12,908,866
Total current liabilities 24,656,793 38,506,061
Total liabilities 24,656,793 38,506,061
Commitments and contingencies
Class A ordinary shares subject to possible redemption; 35,000,000 shares at March 31, 2022 and December 31, 2021, at a redemption value of $10.00 per share 350,055,777 350,027,211
Shareholders' deficit:    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding at March 31, 2022 and December 31, 2021
Accumulated deficit (16,822,854) (17,883,214)
Total shareholders' deficit (16,821,979) (17,882,339)
Total liabilities and shareholders' deficit 357,890,591 370,650,933
Class F Ordinary Shares    
Shareholders' deficit:    
Ordinary shares, value $ 875 $ 875